RCM
ARRY

Rotella Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Rotella Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-23,514
Closed -$99K – 307
2015
Q4 		$99K Sell
23,514
-252,086
-91% -$1.15M 0.09% 318
2015
Q3 		$1.26M Buy
275,600
+245,300
+810% +$1.45M 0.41% 102
2015
Q2 		$218K Buy
+30,300
New +$224K 0.18% 148

Other funds holding ARRY

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Rotella Capital Management's ARRY Position: Q1 2016 in Review

Rotella Capital Management sold out of Array Biopharma Inc (ARRY) in Q1 2016, closing a stake of 23,514 shares — an estimated $99K sold.

Rotella Capital Management first reported a position in ARRY in Q2 2015 and held it in 3 quarters. The position peaked at $1.26M in Q3 2015. 132 funds tracked by Wall St. Rank hold ARRY as of Q1 2016.

  • Rotella Capital Management reported no remaining Array Biopharma Inc position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 23,514 Array Biopharma Inc shares in Q1 2016, an estimated $99K.
  • Rotella Capital Management first reported a position in Array Biopharma Inc in Q2 2015 and held it in 3 quarters.
  • Rotella Capital Management's Array Biopharma Inc position peaked at $1.26M in Q3 2015.
  • 132 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.